liq001
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01224262)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- liq001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01224262 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2010 | Accelovance, Liquidia Technologies, Inc., University of Cincinnati |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Accelovance | For profit | 1 | 0 | 1 | 2010 |
| Liquidia Technologies, Inc. | For profit | 1 | 1 | 1 | 2010 |
| University of Cincinnati | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1